Glycomine
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
733 Industrial Rd, San Carlos, Californi...Phone Number
(650) 264-7560Website
www.glycomine.comRevenue
<$5 MillionIndustry
About Glycomine
Glycomine Inc., founded in 2014, is a private biotechnology company headquartered in San Carlos, California. The company focuses on developing replacement therapies for serious rare genetic disorders, particularly those involving metabolism and protein misfolding. Its lead candidate, GLM101, is a mannose-1-phosphate replacement therapy in clinical development for treating PMM2-CDG (CDG-1a), a congenital disorder of glycosylation. Glycomines approach combines substrates, enzymes, or proteins with targeted delivery systems to restore cellular function, aiming to address unmet medical needs in rare disease communities.Explore more
Glycomine Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Glycomine
Compare insights from companies similar to Glycomine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Glycomine Tech Stack
A closer look at the technologies used by Glycomine
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Glycomine
Sign Up For FreeTo access detailed company insights
Glycomine Inc., founded in 2014, is a private biotechnology company headquartered in San Carlos, California. The company focuses on developing replacement therapies for serious rare genetic disorders, particularly those involving metabolism and protein misfolding. Its lead candidate, GLM101, is a mannose-1-phosphate replacement therapy in clinical... Read More
